Researchers from North Carolina State University have synthesized an analog of lipoxazolidinone A, a small molecule that is effective against drug-resistant bacteria such as MRSA. This molecule, a new synthetic compound inspired by a natural product, could be a useful chemical tool for studying other Gram-positive infections and may have implications for future drug creation.
Lipoxazolidinone A is a natural product which had been previously isolated from bacteria living in marine sediments. It is a secondary metabolite – a small molecule produced by the bacteria that isn’t key to its survival but is produced for a secondary purpose, like defense. When lipoxazolidinone A was initially isolated, researchers noted that it seemed effective against Gram-positive bacteria, like MRSA.
NC State chemist Joshua Pierce aimed to confirm those original findings and understand how the molecule’s structure correlated to its function; in short, he wanted to recreate the molecule to see what portions were directly responsible for its anti-microbial properties and then potentially improve upon that structure.
Pierce, along with current NC State graduate student Kaylib Robinson and former students Jonathan Mills and Troy Zehnder, used novel chemical tools to synthesize lipoxazolidinone A in the lab. They were able to confirm that its chemical structure matched what the initial researchers had indicated, then they worked to identify the portion of the molecule that was responsible for the activity against Gram-positive bacteria. Their result was a compound with improved potency, JJM-35.
They tested JJM-35 against a panel of resistant and non-resistant bacteria. When tested against MRSA in vitro, they found that the synthesized molecule was up to 50 times more effective than the natural product against several bacterial strains. Additionally, they found that the molecule was often more effective against resistant bacterial strains than it was against nonresistant strains.
“An exciting additional aspect of this work was that we identified that these molecules may function by inhibiting multiple biosynthetic pathways directly or indirectly,” says Pierce. “This means that bacteria may have difficulty developing resistance to potential drugs developed from these molecules.”
While more work is needed, Pierce hopes that JJM-35 and similar compounds can be used as tools to study other Gram-positive bacteria and provide a platform for the development of a novel class of anti-infective agents.
“At this point, we have a chemical scaffold – a starting piece of the puzzle. We know that this piece is effective, and so right now all efforts are focused on evaluating the properties of these molecules and their in vivo efficacy,” says Pierce. “The hope is that we can build upon this scaffold to create drugs that are effective against MRSA and other resistant bacteria at a time of dire need for antimicrobial development while also increasing the spectrum of activity.”
The Latest on: Antimicrobial development
via Google News
The Latest on: Antimicrobial development
- Imbed Biosciences Closes $2M Series A Financing on April 18, 2019 at 1:43 pm
based medical device company emerging as a leader in the development of advanced therapies for soft ... intends to use the funds to commercialize its FDA-cleared MicroLyte® Ag Antimicrobial Matrix ... […]
- Imbed Biosciences Closes $2 Million in Series A Financing to Commercialize Its Wound Healing Matrix on April 18, 2019 at 12:29 pm
The funding will be used to commercialize company’s FDA-cleared MicroLyte® Ag Antimicrobial Matrix ... The company has a portfolio of products in development based on its patented MicroLyte ... […]
- Seaweed extract may help design new drugs on April 18, 2019 at 5:58 am
This discovery might lead to the development of new targeted medicines ... which is a rich source of Actinobacteria, may have antimicrobial and anticancer properties that scientists could use to ... […]
- Antimicrobial Resistance: Eritrea conducts a Consensus Building Workshop on a Five year National Action Plan on April 17, 2019 at 11:36 pm
The process of development of the National Action Plan included A Multi ... infection prevention control and antimicrobial use. “A collaborative approach between different sectors, and both political ... […]
- Ghana pilots innovative tool to combat Antimicrobial Resistance (AMR) on April 17, 2019 at 1:38 am
However, the overuse and misuse of antimicrobials can lead to the development of antimicrobial resistance rendering these medications ineffective against routine infections. This further threatens ... […]
- Global Antimicrobial Coatings Market grow at a CAGR of 13.3% by 2024 | top Key Players, Innovations, Growth, Technology, Forecast on April 15, 2019 at 3:35 pm
This analysis provides an examination of different segments that are used to witness the fastest development in the forecast frame of the estimate. Recognize the major market's latest improvements, ... […]
- Antimicrobial Gel Market Overview and Forecast Report 2019| Medline, MPM Medical, B Braun Medical, Sterigear on April 15, 2019 at 12:34 pm
The regional study of the global Antimicrobial Gel market included in the report helps readers to gain a sound understanding of the development of different geographical markets in recent years and ... […]
- Climate Change Could Worsen Antimicrobial Resistance Threat, Scientists Predict on April 13, 2019 at 3:00 pm
Antibiotic resistance, a subset of antimicrobial resistance, is one of the “biggest threats to global health, food security, and development today,” the World Health Organization has said. The authors ... […]
- Global Antimicrobial Susceptibility Test Market 2019 Trends, Top Manufactures, Market Demands, Industry Growth Forecast: 2024 on April 11, 2019 at 2:49 am
Drug Discovery and Development, Others By End Users Diagnostic Laboratories and Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes, Contract Research Organizations ... […]
via Bing News